Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet the Editorial Board Member

Author(s): Seyed Jalal Hosseinimehr

Volume 30, Issue 30, 2023

Published on: 19 April, 2023

Page: [3383 - 3383] Pages: 1

DOI: 10.2174/092986733030230419110829

conference banner
Next »
[1]
Ardakani, J. B.; Abedi, S. M.; Mardanshahi, A.; Shojaee, L.; Zaboli, E.; Khorramimoghaddam, A.; Nosrati, A.; Sabahno, H.; Banimostafavi, E. S.; Hosseinimehr, S. J. Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide. Clinical Breast Cancer, 2023, 23(2), 219-230.
[2]
Ebrahimi, F.; Noaparast, Z.; Abedi, S. M.; Hosseinimehr, S. J. Homodimer (99m)Tc-HYNIC-E(SSSLTVPWY)(2) peptide improved HER2-overexpressed tumor targeting and imaging. Med. Oncol., 2022, 39(12), 204.
[3]
Gharibkandi, N. A.; Molavipordanjani, S.; Mardanshahi, A.; Hosseinimehr, S. J. The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide. Current Drug Metabolism, 2022, 23(1), 82-87.
[4]
Raeispour, M.; Talebpour Amiri, F.; Farzipour, S.; Ghasemi, A.; Hosseinimehr, S. J. Febuxostat, an inhibitor of xanthine oxidase, ameliorates ionizing radiation-induced lung injury by suppressing caspase-3, oxidative stress and NF-κB. Drug and Chemical Toxicology, 2022, 45(6), 2586-2593.
[5]
Ranjbar, V.; Molavipordanjani, S.; Biabani Ardakani, J.; Akhlaghi, M.; Nikkholgh, B.; Hosseinimehr, S. J. Initial preclinical evaluation of 68 Ga-DOTA-(Ser) 3 -LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging. Nucl. Med. Commun., 2022, 43(8), 945-951.
[6]
Seyyedi, R.; Talebpour Amiri, F.; Farzipour, S.; Mihandoust, E.; Hosseinimehr, S. J. Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice. Medical Oncology, 2022, 39(2), 18.
[7]
Ardakani, J. B.; Akhlaghi, M.; Nikkholgh, B.; Hosseinimehr, S. J. Targeting and imaging of HER2 overexpression tumor with a new peptide-based 68Ga-PET radiotracer. Bioorganic chemistry, 2021, 106, 104474.
[8]
Molavipordanjani, S.; Hosseinimehr, S. J. The Radiolabeled HER3 Targeting Molecules for Tumor Imaging. Iranian Journal of Pharmaceutical Research: IJPR, 2021, 20(1), 141.
[9]
Piramoon, M.; Khodadust, F.; Hosseinimehr, S. J. Radiolabeled nanobodies for tumor targeting: From bioengineering to imaging and therapy. Biochimica et Biophysica Acta (BBA)- Reviews on Cancer, 2021, 1875(2), 188529.
[10]
Saednia, S.; Emami, S.; Molavipordanjani, S.; Abedi, S. M.; Amiri, F. T.; Hosseinimehr, S. J. Synthesis and Biological Evaluation of 99mTc-Labeled Phenylpiperazine Derivatives as Selective Serotonin-7 Receptor Ligands for Brain Tumor Imaging. Molecular Pharmaceutics, 2021, 18(6), 2360-2374.

Rights & Permissions Print Cite
Article Metrics
19
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy